Anthropic Nears $15 Billion Credit Deal Ahead of IPO 
US Tech Giants’ AI Bond Boom Raises Euro Zone Borrowing Risks 
Deutsche Telekom Shares Rise as Elliott Pushes Against T-Mobile Merger 
Xiaomi Shares Jump on Europe EV Expansion Plan 
Audi, SAIC Launch China Innovation Hub for New AUDI Models 
OpenAI Rejects Apple Trade Secret Theft Claims 
Lenovo Shares Fall After Dropbox Security Breach Exposes ID Vulnerability 
Lynas Rare Earths Shares Rise After Takeover Talks Revealed 
Nvidia Eyes $2.5 Billion Investment in Thinking Machines Lab 
Shein Shares Drop 5% After Weak Hong Kong IPO Debut 
Microsoft to Reveal Azure Revenue in Major Reporting Shake-Up 
South Korea, US Discuss Chip Investments Amid Tariff Plans 
Fast Retailing Shares Drop as Uniqlo Japan August Sales Fall 
Tesla Cybercab Rides Launch in Austin as NHTSA Reviews Rollout 
Milei Threatens Falkland Oil Firms With Sanctions 
Tesla Cybercab Launch Puts Robotaxi Ambitions in Focus 
OpenAI Launches GPT-6 Astra With Advanced AI Agent Capabilities 
Add as a preferred source on Google
ST. LOUIS, March 02, 2018 -- Stereotaxis, Inc. (OTCQX:STXS), a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will release financial results for its 2017 fourth quarter and full year ended December 31, 2017 on Tuesday, March 6, 2018 before the open of the U.S. financial markets. The Company will host a conference call and webcast at 10:00 a.m. Eastern Time that day to discuss the Company’s results and corporate developments.
| What: | Stereotaxis fourth quarter and full year 2017 financial results conference call | |
| When: | Tuesday, March 6th at 10:00 a.m. Eastern Time (7:00 a.m. PT) | |
| Dial In Number: | To access the live call, dial 877-627-6581 (US and Canada) or 719-325-4790 (International) and give the participant pass code 3267778. | |
| Webcast: | To access the live and replay webcast, please visit the investor relations section of Stereotaxis’ website at www.stereotaxis.com | |
| Call Replay: | A phone replay of the call will be available for one week beginning approximately two hours following the end of the call through Tuesday, March 13, 2018. To access the replay dial-in information, please click here. | |
About Stereotaxis
Stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. Over 100 issued patents support the Stereotaxis platform. The core components of Stereotaxis’ systems have received regulatory clearance in the United States, European Union, Japan, Canada, China, and elsewhere. For more information, please visit www.stereotaxis.com.
Company Contacts:
David L. Fischel
Chairman and Chief Executive Officer
Martin C. Stammer
Chief Financial Officer
314-678-6100
[email protected]
